Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key therapies. Published in the European Journal of Heart Failure, the survey ...
The COVID-19 pandemic revolutionised the uptake of digital technologies for the prevention, diagnosis and treatment of cardiovascular disease. Sign up for the ESC Digital Summit 2021 to hear how ...
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce first and total primary endpoints by 26% and 35%, respectively, in REDUCE-IT patients with prior Myocardial Infarction 2021 ESC ...
Discover how cutting-edge cardiovascular science is set to influence clinical practice in the Asia Pacific region. ESC Asia with APSC & AFC – held online from 2 to 4 December – will cover the full ...
Company’s innovative, integrated imaging systems, devices, software, informatics and services support greater efficiency, enabling high-quality care for a growing volume of complex cardiac patients ...
Two years is a long time in the world of heart failure (HF) management, enough to see publication of more than a dozen studies with insights that would supplant and expand key sections a far-reaching ...
ESOC 2021 New Data on Antithrombotics After ICH: Is There a Net Benefit? New results have been presented from three randomized trials that focused on the use of oral anticoagulant or antiplatelet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback